Lungwort (Pulmonaria officinalis)

Nomenclature & Taxonomic Classification

• Botanical Binomial: Pulmonaria officinalis L.
• Family: Boraginaceae
• Common Name(s): Lungwort, Spotted Mary, Jerusalem Cowslip, Oak Lungs
• Parts Used: Dried aerial parts (leaves and flowering stems).

Botanical Description, Habitat & Sustainability

• Physical Description: * Growth Habit: Low-growing, bristly herbaceous perennial up to 30 cm high.
  • Morphology: Basal leaves are ovate-oblong, distinctly coarse, and covered with prominent, irregular pale white or silver spots (traditionally thought to resemble a diseased lung, evoking the Doctrine of Signatures). Flowers open pink and change to a clear blue-violet as they mature.
• Habitat & Cultivation: Native to European deciduous forests, valleys, and shady hedge banks. Prefers damp, humus-rich, shady soils.
• Sustainability Status: Secure in its native European range, but wild populations should be wildcrafted selectively.

Energetics & Traditional Actions

• Western Tissue States: Corrects Atrophy (dryness) and Irritation (heat/inflammation in lungs).
• Traditional Vector:
  • Ayurveda: Rasa (Taste): Kashaya (Astringent), Tikta (Bitter) | Virya (Energy): Sheeta (Cooling) | Vipaka (Post-Digestive Effect): Katu (Pungent) | Dosha Modulation: Reduces Pitta and Kapha; may increase Vata if used continuously.
  • Traditional Chinese Medicine: Temperature: Cool | Taste: Bitter, Mildly Sweet | Organ Meridians Entered: Lung
• Historical Folk Use: A classic example of the Doctrine of Signatures: because the spotted leaves resembled lung tissue, it was used to treat pulmonary conditions. Highly valued since the Middle Ages to soothe hemoptysis (coughing up blood), asthma, consumption (tuberculosis), and hoarseness.

Phytochemistry & Pharmacological Dynamics

• Primary Phytochemicals: Mucilage polysaccharides, tannins (up to 10%), flavonoids (quercetin, kaempferol), saponins, allantoin, mineral silicic acid (soluble and insoluble silicates), and polyphenol acids (rosmarinic acid).Note regarding Boraginaceae: P. officinalis contains virtually undetectable or negligible trace amounts of saturated pyrrolizidine alkaloids, lacking the toxic 1,2-unsaturated necine ring structure found in comfrey.
• Mechanism of Action: > Lungwort functions through a synergistic demulcent-astringent matrix. The high water-soluble mucilage content coats, hydrates, and physically soothes irritated upper respiratory epithelium. Simultaneously, the tannins gently tone relaxed mucosal structures, reducing capillary exudates and fluid overproduction. Allantoin accelerates cell proliferation, helping to repair minor ulcerations or micro-tears within the respiratory tract.

Clinical Applications & Indications

• Primary Indications: Chronic bronchitis, subacute laryngitis, hacking dry tickling coughs, hoarseness, sore throat, and mild diarrhea.
• Secondary Indications: Hemorrhoids (topical wash), minor skin wounds, and supporting connective tissue health due to its soluble silica content.
• Modern Clinical Evidence: In vitro assays confirm excellent antioxidant and anti-inflammatory activity driven by its rich rosmarinic acid content. Tissue studies validate its traditional use as an effective cough suppressant and soothing agent for inflamed respiratory surfaces.

Preparation, Dosing & Extraction Matrix

• Optimal Menstruum & Extraction Guidelines: Water infusions or low-proof hydroethanolic solvents (25–35% EtOH) are necessary to thoroughly draw out the therapeutic mucilage, tannins, and allantoin. High-proof alcohol precipitates the mucilage and should be avoided.

Standard Dosage Parameters

Safety Profile, Contraindications & Drug Interactions

• Contraindications: While P. officinalis is generally considered free of toxic unsaturated pyrrolizidine alkaloids (PAs), as a precautionary measure, it is best avoided during pregnancy and lactation until comprehensive safety profiles are established.
• Side Effects & Toxicity Thresholds: No known side effects or toxicities when used within standard clinical dosage parameters.
• Pharmaceutical Cross-Interactions: * Enzyme Alterations: None known.
  • Additive Pathways: Absorption Retardation: The mucilage content may minorly delay the absorption of concurrent oral pharmaceutical medications. Space ingestion at least 1 hour apart from critical drugs.

References

1. Gerard, J. (1597). The Herball or Generall Historie of Plantes.
2. Krzyzanowska-Kowalczyk, J., et al. (2018). Phenolic constituents and antioxidant activity of Pulmonaria officinalis. Natural Product Communications, 13(4), 431-434.
3. Gruenwald, J., et al. (2000). PDR for Herbal Medicines. Medical Economics Company.

The initial batch above comprehensively covers Lady’s Mantle, Lavender, Lemon Balm, Lemon Verbena, Lemongrass, Licorice Root, Life Everlasting, Linden, Lovage, and Lungwort.